155 related articles for article (PubMed ID: 12379499)
1. Effect of corticosteroids on human osteoclast formation and activity.
Hirayama T; Sabokbar A; Athanasou NA
J Endocrinol; 2002 Oct; 175(1):155-63. PubMed ID: 12379499
[TBL] [Abstract][Full Text] [Related]
2. Gender- and age-related differences in osteoclast formation from circulating precursors.
Jevon M; Sabokbar A; Fujikawa Y; Hirayama T; Neale SD; Wass J; Athanasou NA
J Endocrinol; 2002 Mar; 172(3):673-81. PubMed ID: 11874715
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
4. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
5. Influence of glucocorticoids on human osteoclast generation and activity.
Sivagurunathan S; Muir MM; Brennan TC; Seale JP; Mason RS
J Bone Miner Res; 2005 Mar; 20(3):390-8. PubMed ID: 15746983
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T; Danks L; Sabokbar A; Athanasou NA
Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
[TBL] [Abstract][Full Text] [Related]
8. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw.
Itonaga I; Hussein I; Kudo O; Sabokbar A; Watt-Smith S; Ferguson D; Athanasou NA
J Oral Pathol Med; 2003 Apr; 32(4):224-31. PubMed ID: 12653862
[TBL] [Abstract][Full Text] [Related]
10. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene.
Matsuzaki K; Katayama K; Takahashi Y; Nakamura I; Udagawa N; Tsurukai T; Nishinakamura R; Toyama Y; Yabe Y; Hori M; Takahashi N; Suda T
Endocrinology; 1999 Feb; 140(2):925-32. PubMed ID: 9927325
[TBL] [Abstract][Full Text] [Related]
11. The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
Fujikawa Y; Sabokbar A; Neale SD; Itonaga I; Torisu T; Athanasou NA
Bone; 2001 Mar; 28(3):261-7. PubMed ID: 11248655
[TBL] [Abstract][Full Text] [Related]
12. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
[TBL] [Abstract][Full Text] [Related]
13. Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones.
Edwards M; Sarma U; Flanagan AM
Bone; 1998 Apr; 22(4):325-9. PubMed ID: 9556131
[TBL] [Abstract][Full Text] [Related]
14. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
Itonaga I; Sabokbar A; Murray DW; Athanasou NA
Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423
[TBL] [Abstract][Full Text] [Related]
15. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
16. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells.
Quinn JM; Neale S; Fujikawa Y; McGee JO; Athanasou NA
Calcif Tissue Int; 1998 Jun; 62(6):527-31. PubMed ID: 9576981
[TBL] [Abstract][Full Text] [Related]
17. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts.
de Vries TJ; Schoenmaker T; Wattanaroonwong N; van den Hoonaard M; Nieuwenhuijse A; Beertsen W; Everts V
J Cell Biochem; 2006 May; 98(2):370-82. PubMed ID: 16440316
[TBL] [Abstract][Full Text] [Related]
18. In vitro generation of mature human osteoclasts.
Hemingway F; Cheng X; Knowles HJ; Estrada FM; Gordon S; Athanasou NA
Calcif Tissue Int; 2011 Nov; 89(5):389-95. PubMed ID: 21960377
[TBL] [Abstract][Full Text] [Related]
19. Rodent osteoblast-like cells support osteoclastic differentiation of human cord blood monocytes in the presence of M-CSF and 1,25 dihydroxyvitamin D3.
Quinn JM; Fujikawa Y; McGee JO; Athanasou NA
Int J Biochem Cell Biol; 1997 Jan; 29(1):173-9. PubMed ID: 9076952
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]